Skip to main content

Healthy Tips To Sleep Better At Night

Avoid prolonged use of light-emitting screens just before bedtime. Consider using room-darkening shades, earplugs, a fan or other devices to create an environment that suits your needs. Doing calming activities before bedtime, such as taking a bath or using relaxation techniques, might promote better sleep. Tips for Better Sleep Be consistent. ... Make sure your bedroom is quiet, dark, relaxing, and at a comfortable temperature. Remove electronic devices, such as TVs, computers, and smart phones, from the bedroom. Avoid large meals, caffeine, and alcohol before bedtime. Get some exercise.
What causes lack of deep sleep? People in pain or discomfort often have difficulty getting deep sleep. Loud noises and bright lights in or near the sleeping environment may also make it difficult to get deep sleep. To get the best possible sleep, sleepers should keep their bedroom dark, quiet, and cool with a comfortable bed and pillows. Healthy Tips To Sleep Better At Night Take A Warm Water Bath Follow up the bath with a glass of warm milk. Regular Exercise It can boost one’s mood and blood circulation and improve the sleep cycle Avoid Caffeine And Alcohol Consumption Practice meditation or deep breathing exercises Avoid Bright Lights Instead, keep a dimly lit light soothing to the eyes if needed. At Least One Hour Before Sleeping Keep away all electronic devices during bedtime. The blue light emitted by these can hamper sleep.

Comments

Popular posts from this blog

Ignoring influenza and flu in winter can be Dangerous

Ignoring influenza (the flu) and flu-like symptoms during the winter can indeed be dangerous. Influenza is a viral infection that primarily spreads through respiratory droplets when an infected person coughs or sneezes. It tends to be more prevalent during the colder months, which is why it's often associated with winter. Here are some reasons why ignoring the flu in winter can be dangerous: Complications: The flu can lead to serious complications, especially in vulnerable populations such as young children, the elderly, pregnant women, and individuals with weakened immune systems. Complications can include pneumonia, bronchitis, sinus infections, and ear infections. Spread of the Virus: Influenza is highly contagious, and neglecting symptoms can contribute to the spread of the virus to others. This is particularly concerning in crowded places like schools, offices, and public transportation. Weakened Immune System: The winter season itself can weaken the immune system, making ...

What Is a Secondary Headache?

A secondary headache is a type of headache that is a symptom of another underlying medical condition or disease. Unlike primary headaches, which are not associated with any underlying cause, secondary headaches are a result of an identifiable and usually serious underlying problem. There are numerous potential causes of secondary headaches, including: Head Injury: Traumatic head injuries can lead to headaches as a symptom. Sinusitis: Inflammation of the sinuses can cause pain and pressure in the head. Migraines: While migraines can be primary headaches, they can also be secondary if they are triggered by an underlying condition. Medication Overuse: Excessive use of pain medications, especially those containing caffeine or codeine, can lead to rebound headaches. Infection: Various infections, such as meningitis, encephalitis, or a sinus infection, can cause secondary headaches. High Blood Pressure: Hypertension (high blood pressure) can lead to headaches, especially if it is seve...

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is mad...